This wiki has undergone a migration to Confluence found Here
Difference between revisions of "20160629 PLA call"
Jump to navigation
Jump to search
(Created page with "{{subst:: PLA Template}}") |
|||
Line 58: | Line 58: | ||
| || Lynn Laakso | | || Lynn Laakso | ||
|- | |- | ||
− | | || Mary Kay McDaniel | + | |Regrets || Mary Kay McDaniel |
|- | |- | ||
| || Brian Pech | | || Brian Pech | ||
Line 85: | Line 85: | ||
===Agenda=== | ===Agenda=== | ||
Agenda review | Agenda review | ||
− | *Notes of [[ | + | *Notes of [[20160615_PLA_call]] review |
+ | *Discussion topics | ||
+ | **Continue to draft mission and charter for CDA mgmt group | ||
+ | |||
*notional division of products into product families and lines, to provide examples for peer review. | *notional division of products into product families and lines, to provide examples for peer review. | ||
**Level of granularity | **Level of granularity | ||
Line 127: | Line 130: | ||
|width="100%" |'''Next Meeting/Preliminary Agenda Items'''<br/> | |width="100%" |'''Next Meeting/Preliminary Agenda Items'''<br/> | ||
− | *[[ | + | *[[20160713 PLA call]] |
|} | |} | ||
© 2016 Health Level Seven® International. All rights reserved | © 2016 Health Level Seven® International. All rights reserved |
Latest revision as of 21:57, 28 June 2016
return to HL7 Product Line Architecture Meeting Minutes and Agendas
Return to HL7 Product Line Architecture Program
HL7 PLA Call Minutes Location: Phone: +1 770-657-9270, Participant Code: 985371, |
Date: 2016-mm-dd Time: 2PM | ||
Facilitator | Mary Kay/ Austin | Note taker(s) | Anne |
Attendee | Name
| ||
Calvin Beebe | |||
Woody Beeler | |||
Lorraine Constable | |||
Bo Dagnall | |||
Jean Duteau, | |||
Rick Haddorff | |||
Tony Julian | |||
Paul Knapp | |||
Austin Kreisler, | |||
Lynn Laakso | |||
Regrets | Mary Kay McDaniel | ||
Brian Pech | |||
John Quinn | |||
John Roberts | |||
Andy Stechishin | |||
no quorum definition |
Agenda
Agenda review
- Notes of 20160615_PLA_call review
- Discussion topics
- Continue to draft mission and charter for CDA mgmt group
- notional division of products into product families and lines, to provide examples for peer review.
- Level of granularity
- Identify which pieces are orphaned, and the political elements to be surfaced.
- Positioning cross-product family artifacts (standards naming)
- BAM-lite feedback and review
- Governance on V2.x (v2.9 substantive changes)
- develop form to request establishing a Product Family
Minutes
Convened
Adjourned
Meeting Outcomes
Actions
|
Next Meeting/Preliminary Agenda Items |
© 2016 Health Level Seven® International. All rights reserved